Jouni started as CEO of Revenio Group Corporation and its' subsidiaries since May 18, 2020. Jouni has experience in international business as well as in the health technology and software businesses. Before joining Revenio, Jouni has worked as CEO at Innokas Medical Oy and Symbio Finland Oy and in executive positions at Nokia UK Ltd and Meridea

Revenio Group Oyj, pörssitiedote, 16.3.2020 klo 16.00. Revenio Group Oyj aloittaa omien osakkeiden hankinnan. Revenio Group Oyj:n hallitus on päättänyt käyttää 20.3.2019 pidetyn yhtiökokouksen antamaa valtuutusta hankkia omia osakkeita ja perustaa osakkeiden takaisinosto-ohjelman.

Tiedotteet Revenio Group Oy, Pörssitiedote, 16.3.2021, klo 9.30. Revenio Research is part of Revenio Group Corporation, a Finnish health tech group listed on Nasdaq Helsinki. Today Revenio Revenio Research Oy. Tel. Learn about REG1V (XHEL) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Katso Finder.fi:stä yhtiön Revenio Group Oyj (1700625-7) yritystiedot, Deloitte Oy, tilintarkastaja; Mikko Petteri Lahtinen, päätilintarkastaja (6/2020). Revenio Group Corporation, Stock Exchange Release, March 19, 2021 at 9.00 EET. Revenio acquires Oculo and strengthens its expertise in clinical eye care Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc.,. Yritys: Revenio Group Oyj, Vantaa - Katso yhteystiedot, taloustiedot sekä uutiset maksutta Tiedot Taloussanomille toimittaa Suomen Asiakastieto Oy. Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices Kauppalehden yritystietopalvelusta löydät yrityksen Revenio Group Oyj taloustiedot, perustiedot, liikevaihdon ja rekisteritiedot.

The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio’s business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio Group Oyj, Pörssitiedote, 20.3.2019 klo 18.00Revenio Group Oyj:n varsinaisen yhtiökokouksen päätökset 20.3.2019 Revenio Group Oyj Yrityksen Revenio Group Oyj (1700625-7) liikevaihto oli 475118 euroa 2018 ja työllisti 6 henkilöä. Liikevaihto nousi 27,4 %.

Yrityksen viime tilikautena 12/2019, Revenio Group Oyj teki 49 474 000 EUR liikevaihtoa ja sen tulos oli 11 557 000 EUR. Yrityksen nettotulosprosentti oli 23,4%.

Aspo Oyj, Aspocomp Group Oyj, Aspro Ocio S.A., Atine Group Oy, Atria Oyj Renideo Holding Oy, Restel Oy, Revenio Group Oyj, Ridgex Investments plc

Revenio seeks vigorous growth in health technology. The Revenio Group comprises, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-led screening, follow-up and the global need to make cost savings in health care via preventive measures. The Revenio Group comprises Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-led screening, follow-up and the global need to make cost savings in health care via preventive measures. Revenio Group on kansainvälisillä markkinoilla toimiva suomalainen terveysteknologiakonserni.

Styrelseledamot i Medix Biochemica Group Oy, Serres Oy, BluePrint Genetics Oy, Ledil Group Oy, Ledil Oy och Revenio Group Oyj. Delegationsmedlem i Raisio

It operates through the Revenio Health Tech segment, Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. About Revenio Group Oyj. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment.
Utsläpp bilar världen

The Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Mar 22, 2021 Revenio Group Acquires Oculo, a Teleophthalmology Platform Company Revenio Research Oy, Done Medical Oy, and Oscare Medical Oy. Revenio Group 53.45 EUR -0.56% Revenio Group Oyj, pörssitiedote, 24.3. 2021 klo 11.10. Tiedotteet Revenio Group Oy, Pörssitiedote, 16.3.2021, klo 9.30. Revenio Research is part of Revenio Group Corporation, a Finnish health tech group listed on Nasdaq Helsinki. Today Revenio Revenio Research Oy. Tel. Learn about REG1V (XHEL) with our data and independent analysis including price, star rating, valuation, dividends, and financials.

Revenio Group Oyj on listattu Nasdaq Helsinki Oy:ssä. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio’s business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio Group Oyj, Pörssitiedote, 20.3.2019 klo 18.00Revenio Group Oyj:n varsinaisen yhtiökokouksen päätökset 20.3.2019 Revenio Group Oyj Yrityksen Revenio Group Oyj (1700625-7) liikevaihto oli 475118 euroa 2018 ja työllisti 6 henkilöä.
Handels kontakta

Revenio Group Oyj, Pörssitiedote, 22.5.2015 kello 10:00. ARVOPAPERIMARKKINALAIN 9 LUVUN 5 PYKÄLÄN MUKAINEN ILMOITUS. Revenio Group Oyj on tänään saanut Arvopaperimarkkinalain 9 luvun 5 pykälän mukaisen ilmoituksen omistusosuuden muuttumisesta, jonka mukaisesti Jyri Merivirran omistusosuus Revenio Group Oyj:n osake- ja äänimäärästä on laskenut alle yhden kymmenesosan …

2021-03-19 Puh. 010 665 8110 (ark.

Revenio Group Oyj: Icare Finland aloittaa silmänpaineen kotimittareiden myynnin suoraan Revenio Group Oyj: Revenio on ostanut Oscare Medical Oy:n

0.00%. 0.0000. 1.33B. 117.30. 0.42. Hälsoteknologi · Medicinska specialiteter · TTALO.

Tel. Revenio Group Oyj. VANTAA. Tel. +358 20 525 3000 Försäljning av Alte Oy till Alten Group S.A. Kund: Alte Group Oy Roima Intelligence Oy's köp av Done software solutions Oy från Revenio Oyj 06/2015. Indutrade AB, 4,27. Addtech AB Class B, 4,19. Lifco AB Class B, 3,75.